These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase, alanine aminopeptidase and lysozyme in patients with renal disease. Palmieri L; Ronca G; Cioni L; Puccini R Contrib Nephrol; 1984; 42():123-9. PubMed ID: 6152415 [No Abstract] [Full Text] [Related]
3. [Studies of hydrogen ion excretion in renal diseases]. Raszeja-Wanic B Med Dosw; 1968 Apr; 38():271-307. PubMed ID: 5761590 [No Abstract] [Full Text] [Related]
4. [Renal magnesium and calcium excretion during a magnesium load, related to renal function (author's transl)]. Bauditz W; Osterloh R Res Exp Med (Berl); 1974; 164(2):111-21. PubMed ID: 4438843 [No Abstract] [Full Text] [Related]
5. [Glucose excretion in patients suffering from kidney diseases]. Heimsoth VH; Graffe-Achelis C Verh Dtsch Ges Inn Med; 1971; 77():210-2. PubMed ID: 5155834 [No Abstract] [Full Text] [Related]
6. Gamma-glutamyl transpeptidase activity in human urine. Salgó L; Szabó A Clin Chim Acta; 1982 Nov; 126(1):9-16. PubMed ID: 6129082 [TBL] [Abstract][Full Text] [Related]
7. Serum levels and urinary excretion of alpha- 2 -macroglobulin in patients with renal disease. Hedfors E; Kistner S; Norberg R Acta Med Scand; 1971 Nov; 190(5):347-51. PubMed ID: 5149261 [No Abstract] [Full Text] [Related]
9. [Gamma-glutamyl transpeptidase activities in 24-hour urine in various forms of kidney disease (author's transl)]. Bahre G; Kley R; Brass H Dtsch Med Wochenschr; 1974 Nov; 99(44):2214-8. PubMed ID: 4154192 [No Abstract] [Full Text] [Related]
10. [Behavior of certain forms of enzymuria in subjects treated with pipemidic acid]. Clemenzia G; Russo G; Gentile V; Liberti M; Perugia G; Scibinetti F; Gallo G; Dragonetti E; Rainoni M Minerva Med; 1986 Apr; 77(16):621-6. PubMed ID: 2871528 [TBL] [Abstract][Full Text] [Related]
11. [Selectivity of urinary protein excretion in patients with chronic parenchymatous nephropathies]. Rohrer T; Fischer L; Fuhrmann C; Hodler J Schweiz Med Wochenschr; 1973 Jan; 103(4):131-40. PubMed ID: 4683727 [No Abstract] [Full Text] [Related]
12. [ Urinary sedimentation in the diagnosis of renal diseases]. Piccoli G; Rotunno M G Clin Med; 1988 Oct; 69(10):595-9. PubMed ID: 3229609 [No Abstract] [Full Text] [Related]
13. [Elimination of the antibiotic cephacetril in patients with impaired renal function]. Spring P; Räber J; Reber H; Dettli L Schweiz Med Wochenschr; 1973 May; 103(21):783-8. PubMed ID: 4704362 [No Abstract] [Full Text] [Related]
14. Urinary protein excretion in interstitial and tubular kidney disease as characterized by gradient electrophoresis. Alt JM; Hacke M; von der Heyde D; Jänig H; Junge PM; Olbricht C; Schurek HJ; Stolte H Klin Wochenschr; 1983 Jul; 61(13):641-8. PubMed ID: 6350693 [No Abstract] [Full Text] [Related]
16. Urinalysis and clinical renal disease. Szwed JJ Am J Med Technol; 1980 Oct; 46(10):720-5. PubMed ID: 7211937 [TBL] [Abstract][Full Text] [Related]
17. [ Relationship between the renal excretion of chromium and urine flow in normal and renal diseased persons (author's transl)]. Mertz DP; Wilk G Res Exp Med (Berl); 1977 Jun; 170(2):193-201. PubMed ID: 882716 [No Abstract] [Full Text] [Related]
18. [Analysis of cellular composition of the urinary sediment in kidney diseases]. Kozlovskaia LV; Poliantseva LR; Tareeva IE; Androsova SO; Kochubeĭ LN Urol Nefrol (Mosk); 1975; (1):16-20. PubMed ID: 1118965 [No Abstract] [Full Text] [Related]
20. [On the pharmacokinetics of sulfamethoxypyrazine in chronic liver and kidney diseases]. Held H; von Berger L; von Oldershausen HF Arzneimittelforschung; 1969 Jan; 19(1):98-100. PubMed ID: 5819372 [No Abstract] [Full Text] [Related] [Next] [New Search]